45 research outputs found
A Spatiotemporal-chaos-based Encryption Having Overall Properties Considerably Better Than Advanced Encryption Standard
Spatiotemporal chaos of a two-dimensional one-way coupled map lattice is used
for chaotic cryptography. The chaotic outputs of many space units are used for
encryption simultaneously. This system shows satisfactory cryptographic
properties of high security; fast encryption (decryption) speed; and robustness
against noise disturbances in communication channel. The overall features of
this spatiotemporal-chaos-based cryptosystem are better than chaotic
cryptosystems known so far, and also than currently used conventional
cryptosystems, such as the Advanced Encryption Standard (AES).Comment: 11 pages, 3 figure
Sino-European Transcontinental Basic and Clinical High-Tech Acupuncture Studies—Part 2: Acute Stimulation Effects on Heart Rate and Its Variability in Patients with Insomnia
This second part of a series of Sino-European high-tech acupuncture studies describes the first clinical transcontinental teleacupuncture measurements in patients with insomnia. Heart rate (HR) and heart rate variability (HRV) measurements in 28 patients (mean age ± SD: 41.9 ± 14.6 years) were performed under standardized conditions in Harbin, China, and the data analysis was performed in Graz, Austria. Similar to the first part of the series, the electrocardiograms (ECGs) were recorded by an HRV Medilog AR12 system during acupuncture of the Shenmen point (HT7) on the left hand. HR decreased significantly (P < 0.001) during and after acupuncture stimulation of the HT7 acupuncture point. Total HRV increased significantly (P < 0.05) immediately after acupuncture stimulation, but there was no long-lasting effect. The values of the low-frequency (LF) and high-frequency (HF) band increased significantly after the stimulation compared to baseline values; however, the LF/HF ratio showed no significant changes. Together with the results of previous studies, the present results can serve as a solid basis for further development of acupressure or acupuncture stimulation equipment for complementary use in treating insomnia
Biomedical Teleacupuncture between China and Austria Using Heart Rate Variability, Part 1: Poststroke Patients
Background. Acupuncture has been reported to affect the human autonomic system. Within this pilot study, teleacupuncture between China and Austria is used for the first time for quantifying the effects of heart rate variability (HRV) in poststroke rehabilitation. Methods. In 29 Chinese post-stroke patients (15 f, 14 m; mean age ± SD 64.7 ± 11.3 years; range 40–80 years) electrocardiographic signals before, during, and after acupuncture at the acupoint Tongli (HT 5) were recorded in Harbin and analyzed in Graz using teleacupuncture via internet. HRV data were analyzed in the time and frequency domain, and a protocol from Austria was sent to the team in China immediately after the treatment and recording session. Results. Acupuncture does not change heart rate in the post-stroke patients; however, total HRV increased significantly (P < .05) during and 5–10 minutes after acupuncture. In addition, balance between sympathetic and parasympathetic activity (low frequency/high frequency HRV ratio) changes markedly during treatment. Conclusions. Based on innovative HRV analysis, it could be demonstrated that teleacupuncture between China/Harbin and Austria/Graz over a distance of about 8,500 km is no longer a future vision; it has become reality
Experimental realization of a highly secure chaos communication under strong channel noise
A one-way coupled spatiotemporally chaotic map lattice is used to contruct
cryptosystem. With the combinatorial applications of both chaotic computations
and conventional algebraic operations, our system has optimal cryptographic
properties much better than the separative applications of known chaotic and
conventional methods. We have realized experiments to pratice duplex voice
secure communications in realistic Wired Public Switched Telephone Network by
applying our chaotic system and the system of Advanced Encryption Standard
(AES), respectively, for cryptography. Our system can work stably against
strong channel noise when AES fails to work.Comment: 15 pages, 5 figure
Biomedical Teleacupuncture between China and Austria Using Heart Rate Variability—Part 2: Patients with Depression
It has been shown in previous studies that the autonomic nervous system can be affected by acupuncture. Within this study, teleacupuncture between China and Austria is used for quantifying the effects of heart rate (HR) and heart rate variability (HRV) in 33 Chinese patients (27 females, 6 males; mean age ± SD 49.5 ± 13.1 years; range 22–72 years) suffering from depression. Electrocardiographic signals before, during, and after acupuncture at the acupoint Baihui (GV20) were recorded in Harbin and analyzed in Graz using teleacupuncture. HRV data were analyzed in the time and frequency domain. Mean HR decreased significantly (P < 0.05) during and after acupuncture, whereas total HRV increased significantly after the third acupuncture stimulation period (P < 0.05) and also 5–10 minutes after (P < 0.05) acupuncture. The study shows that HRV could be a useful parameter for quantifying clinical effects of acupuncture on the autonomic nervous system
Quantum optics of a Bose-Einstein condensate coupled to a quantized light field
We consider the interaction between a Bose-Einstein condensate and a
single-mode quantized light field in the presence of a strong far off-resonant
pump laser. The dynamics is characterized by an exponential instability, hence
the system acts as an atom-photon parametric amplifier. Triggered by a small
injected probe field, or simply by quantum noise, entangled atom-photon pairs
are created which exhibit non-classical correlations similar to those seen
between photons in the optical parametric amplifier. In addition, the quantum
statistics of the matter and light fields depend strongly on the initial state
which triggers the amplifier. Thus by preparing different initial states of the
light field, one can generate matter waves in a variety of quantum states,
demonstrating optical control over the quantum statistics of matter waves
Endpoint estimates for vector-valued multilinear commutator of fractional area integral operator
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials.
Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure.
Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen.
Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049